'Operation Cure.All' Wages New Battle In War Against Internet Health
Fraud
by Peter Graham
The Food & Drug
Administration and other law enforcement agencies took steps to stop scams
for supplements and other products that purport to cure cancer, HIV/AIDS
and countless other life-threatening diseases. The FDA also warns of risks
associated with some supplements, including drug interactions.
As part of an ongoing and
comprehensive law enforcement and consumer education campaign begun
in 1997, the Federal Trade Commission today announced a new round of
enforcement actions against the fraudulent marketing of supplements
and other health products on the Internet. The FTC's action is part
of a coordinated effort with the U.S. Food and Drug Administration (FDA),
Health Canada, and various state Attorneys General to crack down on
unscrupulous marketers who use the Internet to prey on the sickest and
most vulnerable consumers.
The
six new FTC enforcement actions target companies marketing a variety
of devices, herbal products, and other dietary supplements to treat
or cure cancer, HIV/AIDS, arthritis, hepatitis, Alzheimer's, diabetes
and many other diseases. Among the many products for which unfounded
claims were being made were a DHEA hormonal supplement, St. John's Wort,
various multi-herbal supplements, colloidal silver and a variety of
electrical therapy devices. The cases were also prompted by representations
by some marketers that their products are safe when, in fact, there
may be potentially dangerous interactions with other medications.
Among the many false and
unsubstantiated claims challenged in today's cases were promises that:People
could cancel their surgery, radiation or chemotherapy in favor of herbal
cures that cost hundreds of dollars; A device that delivered mild electric
current would kill the parasites that cause such serious diseases as
cancer and Alzheimer's; and Those with HIV or AIDS could use St. John's
Wort as a safe treatment for the disease. In fact, the FTC alleged,
there is inadequate evidence to support the use of the herb to treat
AIDS. Indeed, St. John's Wort is known to interfere with proven HIV/AIDS
medications.
"Many of
the Web sites targeted today are jeopardizing the health and safety
of consumers with outlandish promises and false hope," said FTC Chairman
Timothy J. Muris. "Unfortunately, examples of questionable products
being peddled on the Web abound, and the Federal Trade Commission, with
its partners, will step up its efforts to protect consumers from these
compelling, but deceptive health claims."
"Health
Canada fully shares the concerns of the U.S. FDA and FTC about the potential
public health risks involved in the marketing of untested, unlicensed,
and in some cases, fraudulent and dangerous drugs and devices. In an
era of globalization, it is a problem that knows no borders, and intergovernmental
cooperation is essential. Health Canada accordingly welcomes opportunities
to work with its U.S. and other international counterparts to ensure
that devices and drugs are safe and effective, and that they are compliant
with the regulations and laws put in place to protect the public," said
Daniéle Dionne, Associate Director General, Health Products and Food
Branch, Health Canada.
Today's
announcement by the FTC marks the fourth group of targeted enforcement
actions to address marketing of unproven health products on the Internet.
The cases in this phase of "Operation Cure.All," like earlier cases,
often involve dramatic treatment and cure claims, often for a multitude
of serious diseases. Some of the cases also raise serious safety implications.
Moreover,
two cases challenge the promotion of St. John's Wort as a safe treatment
for HIV/AIDS, a claim that presented serious drug interaction risks.
In February 2000, FDA issued a Public Health Advisory to alert health
care providers and consumers to the results of an NIH study and other
reports in the medical literature indicating that taking St. John's
Wort may cause a loss of therapeutic effect for any drug metabolized
along the same specified pathway, including HIV medications, drugs to
prevent transplant rejection, and oral contraceptives.
The Advisory
is posted on FDA's web site at: www.FDA.gov. "Many herbal products and other supplements are
promoted as natural and having no side effects. We want consumers to
understand that these products are pharmacologically active and can
be very potent. Patients know to be careful not to mix medications without
consulting their doctor, pharmacist, or health care professional. They
need to be just as cautious about combining supplements with their medications,"
cautioned Chairman Muris.
"It's bad
enough when someone, with little or no evidence, touts unproven remedies
to vulnerable populations such as people infected with HIV/AIDS; it's
even more frightening when they do so despite -- and without so much
as a mention of -- emerging risks that those remedies pose to the very
people to whom they are pitching their sale. St. John's Wort and protease
inhibitors: THEY DON'T MIX." said Walter H. Carr, Partnership Council
Chairman of the National AIDS Health Fraud Task Force Network.
To alert
consumers to the drug interaction risks, today's actions by the FTC
will require the two companies that had been promoting St. John's Wort
as a safe treatment for HIV and other diseases to include a disclosure
warning of interaction risks in certain future marketing of St. John's
Wort products.
In the six
FTC cases announced today, the companies were charged with making false
and unsubstantiated health and safety claims for a variety of products
advertised on the Internet. Five of the companies agreed to settle the
charges and the proposed settlement agreements were announced today
for public comment. The Commission has filed a complaint in federal
district court against the sixth company.
Panda
Herbal International, Inc., also doing business as Viable Herbal Solutions,
and its owner, Everett L. Farr III
According
to the agency, Panda Herbal International, based in Bensalem, Pennsylvania,
and its owner, Everett L. Farr III, marketed and sold two products:
"Herbal Outlook" - a dietary supplement that contains St. John's Wort;
and "Herb Veil 8," -- a topical ointment. Panda claimed that consumers
could safely use Herbal Outlook to treat such diseases as HIV/AIDS,
herpes simplex, tuberculosis, influenza and hepatitis B infections.
They also claimed that ingestion of Herbal Outlook has no known contraindications
or drug interactions. In addition, the respondents claimed that Herb
Veil 8 is effective in the treatment of carcinomas, adenocarcinomas
and melanomas. The complaint alleges that the Herbal Outlook and Herb
Veil 8 treatment claims are unsubstantiated and that the claim that
Herbal Outlook has "no known contraindications or drug interactions"
is false.
The proposed
settlement would resolve the charges by prohibiting Panda from making
any unsubstantiated claims that Herb Veil 8, Herbal Outlook, or any
covered product or service, is effective in the mitigation, treatment,
prevention, or cure of any disease or illness, or about the health benefits,
performance, safety, or efficacy of any such product. The proposed consent
order would require the respondents to place a disclosure warning in
any advertisement, promotional material or product label for any Herbal
Outlook or similar product that states:
WARNING:
St. John's Wort can have potentially dangerous interactions with some
prescription drugs. Consult your physician before taking St. John's
Wort if you are currently taking anticoagulants, oral contraceptives,
antidepressants, anti-seizure medications, drugs to treat HIV or prevent
transplant rejection, or any other prescription drug. This product is
not recommended for use if you are or could be pregnant unless a qualified
health care provider tells you to use it. The product may not be safe
for your developing baby.
The disclosure
would be required in connection with any claim made about the efficacy,
performance, or safety of such product. This disclosure was developed
after discussions with the FDA. FDA has announced that it intends to
initiate a rulemaking for dietary supplements for women who are or who
may become pregnant. In the event that FDA issues a final rule requiring
a warning for pregnant women on dietary supplements, respondents must
substitute that warning for the relevant part of the FTC disclosure.
In addition,
the settlement would require Panda to send a notice to all purchasers
of Herbal Outlook and Herb Veil 8 informing them of the Commission's
settlement, and to offer full refunds upon request to consumers who
purchased HerbVeil 8 products during the relevant time period.
ForMor,
Inc., doing business as ForMor International, and its president, Stan
Gross
ForMor,
Inc., based in Conway, Arkansas, and its president, Stan Gross, made
numerous health-related claims for the products: St. John's Kava Kava,
colloidal silver, and Ultimate II Shark Cartilage Concentrate. ForMor
made claims that ingestion of St. John's Kava Kava, a product containing
St. John's Wort and other herbs, is effective in the treatment of HIV/AIDS,
colds, syphilis, tuberculosis, dysentery, whooping cough, mania, hypochondria,
fatigue and hysteria. The complaint also alleges that ForMor failed
to disclose that ingestion of St. John's Kava Kava is not compatible
with use of protease inhibitors used in the treatment of HIV/AIDS. ForMor
also falsely represented that ingestion of St. John's Kava Kava has
no serious drug interactions.
In addition,
ForMor claimed that ingestion of colloidal silver is proven effective
in treating over 650 infectious diseases, and that medical tests prove
that ingestion of colloidal silver is safe and has no adverse side effects.
The company also claimed that ingestion of colloidal silver is effective
in the treatment of arthritis, blood poisoning, cancer, cholera, diphtheria,
diabetes, dysentery, gonorrheal herpes, influenza, leprosy, lupus, malaria,
meningitis, rheumatism, shingles, staph infections, strep infections,
syphilis, tuberculosis, whooping cough, and yeast infections.
Further,
the company claimed that shark cartilage pills are effective in the
treatment of arthritis and other degenerative and inflammatory conditions;
scientific research establishes that ingestion of shark cartilage is
effective in the treatment of arthritis and other degenerative and inflammatory
conditions; and ingestion of shark cartilage is effective in the treatment
of brain cancer. The complaint alleges that these claims are false or
unsubstantiated.
The proposed
settlement would resolve the charges by prohibiting the ForMor respondents
from making the specific health claims for its St. John's Wort, colloidal
silver and shark cartilage treatments, unless they have competent and
reliable scientific evidence to support such claims, and from misrepresenting
the results of any tests, study or research.
The settlement
would require the respondents, in connection with any claim about the
performance, benefits, safety, or efficacy of any product containing
St. John's Wort, to place a disclosure in any advertisement, promotional
material or product label for the product. The disclosure language and
the provision for substituting warning language promulgated by FDA parallel
that in the Panda settlement described above.
In addition,
the settlement would require ForMor to send a notice to all purchasers
of St. John's Kava Kava, colloidal silver, and Ultimate II Shark Cartilage
Concentrate informing them of the Commission's settlement and would
require them to give refunds upon request to people who purchased colloidal
silver and Ultimate II Shark Cartilage Concentrate during the relevant
time period.
MaxCell
BioScience, Inc., also doing business as Oasis Wellness Network, and
its president, Stephen Cherniske
MaxCell
BioScience, based in Broomfield, Colorado, and its president, Stephen
Cherniske, marketed and sold dietary supplements through a multi-level
marketing scheme. The respondents made numerous allegedly false and
unsubstantiated health claims in cassette and audio and video tapes,
as well as on their Web site, for two products: "Longevity Signal Formula"
("LSF") - a dietary supplement containing the hormone DHEA; and their
at-home urine test called the "Anabolic/Catabolic IndexÖ² Test" ("ACI
Test").
MaxCell claimed
that LSF reverses the aging process and prevents, treats or cures numerous
age-related diseases and conditions, including atherosclerosis, arthritis,
high blood pressure, elevated cholesterol levels, weight gain, and poor
liver function. They also claimed that their ACI Test provided a clinical
gauge of an individual's overall healthiness and youthfulness.
The proposed
settlement would prohibit the respondents from making unsubstantiated
health claims and from disseminating deceptive marketing material to
distributors. It would prohibit the respondents from making any representations
about the health benefits of their products or any other food, dietary
supplement or drug, without adequate substantiation. In addition, it
would require MaxCell to pay $150,000 for consumer redress to the FTC,
and to notify their distributors of the settlement and warn them of
possible termination if they do not conform their representations to
the requirements placed on MaxCell.
Robert
C. Spencer and Lisa M. Spencer, doing business as Aaron Company
Robert C.
Spencer and Lisa M. Spencer, d/b/a Aaron Company, based in Palm Bay,
Florida, sold three products: Colloidal Silver - a dietary supplement
allegedly containing suspended particles of silver, intended to be taken
orally for the cure and treatment of more than 650 diseases; Chitosan
with vitamin C -- a tablet purportedly containing chitin for weight
loss; and Ultimate Energizer -- a product containing ephedra (ma huang)
marketed as a stimulant.
The complaint
alleges that the respondents disseminated deceptive advertising for
Colloidal Silver, Chitosan with vitamin C and Ultimate Energizer through
the Internet. The ads allegedly contained false and unsubstantiated
claims in the text of the site, as well as in the embedded source code
or "metatags" for the Web site, that the colloidal silver product has
been medically proven to kill over 650 disease-causing organisms in
the body; that its colloidal silver product is effective in curing diseases
ranging from cancer and multiple sclerosis to HIV/AIDS; and that its
colloidal silver product was medically proven to work.
The complaint
also alleges that the respondents made unsubstantiated claims that the
Chitosan product enables consumers to lose substantial weight without
a restricted calorie diet and that the Ultimate Energizer product, which
contains ephedra (ma huang), a natural source of ephedrine, is safe
and has no side effects.
The proposed
settlement would prohibit the respondents from making the types of claims
alleged in the complaint, unless they have competent and reliable scientific
evidence to substantiate those claims. The proposed settlement would
require the respondents to possess competent and reliable scientific
evidence to substantiate any future claim that any covered product or
service is effective in mitigating, treating, preventing, or curing
any disease, illness or health condition; or about the health benefits,
performance, safety, or efficacy of any such product or service.
In addition,
they would be prohibited from misrepresenting the results of any tests,
studies or research. The order would also require that all future advertising
and labeling of products containing ephedra include affirmative disclosures
concerning the serious risks associated with that botanical. The primary
warning would state:
WARNING:
This product contains ephedra or ephedrine alkaloids, which can have
dangerous effects on the central nervous system and heart and can result
in serious injury. Risk of injury can increase with dose, and may even
include heart attack, stroke, seizure or death. Consult a healthcare
provider prior to use if you have high blood pressure, heart or thyroid
disease, diabetes, difficulty urinating, prostate enlargement, or glaucoma,
or are using any prescription drug. Do not use if you are taking a MAO
inhibitor or any allergy, asthma, or cold medication containing ephedrine,
pseudoephedrine or phenylpropanolamine. Discontinue use if you experience
rapid heart beat, chest pain, severe headache, shortness of breath,
dizziness, sleeplessness or nausea. This product is not recommended
for use if you are or could be pregnant unless a qualified health care
provider tells you to use it. The product may not be safe for you or
your developing baby.
A shorter
warning is permitted for television and radio advertisements. The warning
was developed after discussions with FDA and contains a provision parallel
to that in Panda and ForMor.
Michael
Forrest, doing business as Jaguar Enterprises of Santa Ana, also known
as Jaguar Enterprises
Michael
Forrest, d/b/a Jaguar Enterprises, based in Mesquite, Texas, and using
business addresses in Black Mountain, North Carolina and Miami, Flordia,
sold, distributed, promoted, and advertised various products, including
various electronic therapy devices known as the Black Box; Magnetic
Pulser; Magnetic Multi-Pulser; Beck-Rife unit; Portable Rife Frequency
Generator; PC-Rife #1; PC-Rife #2; PC-Rife #3; as well as a combination
of herbal ingredients known as "Miracle Herbs," a purported cure for
cancer and other serious diseases.
The complaint
alleges that Jaguar made unsubstantiated claims that their electronic
devices will cure or prevent serious diseases, such as cancer, AIDS,
arthritis, Gulf War Syndrome, and Chronic Fatigue Syndrome, by passing
an electric current or magnetic pulse through the body, and that Miracle
Herbs is effective in treating cancer of all types, AIDS, bacterial
and viral infections. It also alleges that the respondent falsely represented
that Miracle Herbs has been scientifically proven to be safe and effective
and that the electronic devices have been scientifically proven to kill
bacteria and viruses and other parasites in the body.
The proposed
settlement would prohibit the respondent from making the challenged
claims or any other claim about the health benefits, performance, safety
or efficacy of its products or services without adequate substantiation.
The settlement also would prohibit the respondent from misrepresenting
the results of any test, study or research. Finally, the settlement
requires the respondent to offer refunds to purchasers of the challenged
products.
Western
Dietary Products Co., doing business as Western Herb & Dietary Products,
Inc. and its owners Marvin and Miguelina Beckwith
The complaint
against Western Dietary Products, based in Blaine, Washington, and Marvin
and Miguelina Beckwith, the company's owners, charges that the defendants
marketed various herbal formulas and herbal cure packages including
Black Walnut Tincture, Wormwood Tincture, and Cloves Tincture to treat
and cure cancer, Alzheimer's, diabetes, arthritis, and HIV/AIDS; that
they marketed the "Zapper Electrical Unit" to treat and cure Alzheimer's
and HIV/AIDS; and that the defendants claimed their herbal products
would make surgery and chemotherapy unnecessary for persons with cancer.
According to the complaint, all of these claims were unsubstantiated.
The complaint against Western Dietary Products Co. was filed in the
U.S. District Court for the Western District of Washington, in Seattle,
on June 4, 2001. At a June 13th hearing, the defendants agreed to entry
of a preliminary injunction.
FDA
As part
of the coordinated Cure.All effort, the FDA is also highlighting a variety
of initiatives it has taken in the past year to combat Internet Health
Fraud.
Colloidal
Silver
The FDA
and FTC have identified firms that marketed Colloidal Silver as a cure,
treatment, or prevention of serious diseases. As part of Cure.All, the
FDA identified forty-eight (48) Web sites that made serious drug claims
for Colloidal Silver, as well as a number of other products. The FDA
sent these Web sites Cyber Letters, untitled letters sent via electronic
mail, informing them that their products were being promoted for conditions
that may cause the products to be considered drugs and therefore may
be in violation of the Federal Food, Drug, and Cosmetics Act. As a direct
result of these Cyber Letters, 27 percent of the sites complied by removing
or changing the violative claims.
Rife
Frequency Generators and Zappers
Rife Frequency
Generators and Zappers are devices that purportedly send different amounts
of electrical energy into the body to destroy parasites and/or shatter
cells to cure serious diseases, such as cancer and AIDS. As part of
"Operation Cure All," the FDA has taken several actions with respect
to these devices:
FDA issued
warning letters to several firms selling these devices informing them
that they were in violation of the Federal Food, Drug, and Cosmetic
Act. FDA also issued several untitled letters to firms questioning the
legality of the marketing of these devices. Most of these firms have
either removed or modified their Web sites; and FDA placed the Zapper
promoted by one foreign firm on automatic detention without physical
examination, which will prevent this device from legally entering the
United States.
Aristolochic
Acid
The FDA
has determined that aristolochic acid -- a substance found in some traditional
herbal medicines -- poses significant health risks to consumers because
it is carcinogenic and extremely toxic to the kidney. FDA has taken
several actions in response to the marketing of dietary supplements
containing aristolochic acid:
FDA has
issued two public warnings to consumers, health care providers, and
dietary supplement manufacturers; FDA has prohibited the importation
of botanicals that are suspected to contain or be contaminated with
aristolochic acid, unless firms can prove that their products are free
of the toxic substance; FDA has warned manufacturers that they must
take steps to ensure that their products are free of these toxic substances;
FDA has issued warning letters to several firms informing them that
their products are adulterated within the meaning of the Food, Drug,
and Cosmetic Act, present a significant risk to consumer health, and
should be immediately recalled from the marketplace; and FDA has worked
with a number of firms to initiate recalls of the affected products
and ensure that customers were immediately notified.
Consumer
Education
In addition
to announcing today's enforcement actions, the FTC will continue its
education campaign to alert consumers to health fraud online. Because
promoters of fraudulent healthcare products often use similar claims
and practices to lure consumers into buying their products, the FTC
advises consumers to be suspicious of:
Claims that
the product is "natural" or "non-toxic," suggesting it does not have
side effects. "Natural" or "non-toxic" does not necessarily mean safe.
Some "natural" supplements contain potent stimulants; others, like St.
John's Wort, can result in negative interactions with medicines. Testimonials
from people who claim amazing results. Testimonials often are undocumented
and are not a substitute for scientific proof. Claims that a product
is a "scientific breakthrough," "miraculous cure," "secret ingredient"
or "ancient remedy." Claims that the product is an effective cure for
a wide range of ailments. Claims that use impressive-sounding medical
terms. Claims that the product is available from only one source, and
payment is required in advance. Claims of a "money-back" guarantee.
Websites that fail to list the company's name, physical address, phone
number or other contact information.
__________________________
Peter Graham is a staff writer for Insider Reports®:
The Right Advice @ The Right Time
Information and resources to help you do it yourself since 1987. Author Profile
|